复方倍他米松疼痛区域皮内注射对胸背部带状疱疹后遗神经痛的效果

丁永永, 邓红, 刘兵

丁永永, 邓红, 刘兵. 复方倍他米松疼痛区域皮内注射对胸背部带状疱疹后遗神经痛的效果[J]. 实用临床医药杂志, 2019, 23(10): 65-68. DOI: 10.7619/jcmp.201910018
引用本文: 丁永永, 邓红, 刘兵. 复方倍他米松疼痛区域皮内注射对胸背部带状疱疹后遗神经痛的效果[J]. 实用临床医药杂志, 2019, 23(10): 65-68. DOI: 10.7619/jcmp.201910018
DING Yongyong, DENG Hong, LIU Bing. Effect of intradermal injection of compound betamethasone in pain area on post-herpetic neuralgia in thoracic and dorsal regions[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 65-68. DOI: 10.7619/jcmp.201910018
Citation: DING Yongyong, DENG Hong, LIU Bing. Effect of intradermal injection of compound betamethasone in pain area on post-herpetic neuralgia in thoracic and dorsal regions[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 65-68. DOI: 10.7619/jcmp.201910018

复方倍他米松疼痛区域皮内注射对胸背部带状疱疹后遗神经痛的效果

详细信息
  • 中图分类号: R752.1

Effect of intradermal injection of compound betamethasone in pain area on post-herpetic neuralgia in thoracic and dorsal regions

  • 摘要:
      目的  探讨复方倍他米松疼痛区域皮内注射对胸背部带状疱疹后遗神经痛的效果。
      方法  前瞻性研究140例胸背部带状疱疹合并后遗性神经痛患者的诊疗情况,将所选患者随机分为对照组与观察组,各70例。对照组实施皮内注射地塞米松+神经阻滞,并给予加巴喷丁口服治疗; 观察组实施皮内注射复方倍他米松+神经阻滞,并给予加巴喷丁口服治疗。2组患者均治疗8周。2组患者于首次皮内注射后应用曲马多缓释片治疗(100 mg), 每12 h服1次,根据疼痛情况调整用药,最长服用1周后停止。观察并比较2组患者的疗效、治疗前后视觉模拟评分法(VAS)评分、曲马多缓释片用药量、治疗前后睡眠质量(QS)评分及不良反应情况。
      结果  观察组患者的治疗总有效率(98.57%)显著优于对照组(75.71%) (P < 0.05); 2组患者治疗前的VAS评分差异无统计学意义(P>0.05); 治疗后, 2组患者的VAS评分均较治疗前显著降低,且观察组评分显著低于对照组(P < 0.05); 观察组的曲马多缓释片用药量为(698.50±96.50) mg, 显著低于对照组的(1 289.50±169.50) mg(P < 0.05); 2组患者不良反应情况差异无统计学意义(P>0.05)。
      结论  采用复方倍他米松疼痛区域皮内注射治疗胸背部带状疱疹后遗神经痛的患者,其治疗效果优于应用地塞米松的患者。
    Abstract:
      Objective  To investigate the effect of intradermal injection of compound betamethasone in pain area on post-herpetic neuralgia in thoracic and dorsal regions.
      Methods  A prospective study was conducted for 140 herpes zoster cases with post-herpetic neuralgia treated in our hospital. The included patients were randomly divided into control group(n=70) and observation group(n=70). The control group received intradermal injection of dexamethasone plus nerve block, as well as oral administration of gabapentin, while the observation group was given intradermal injection of compound betamethasone plus nerve block, and oral administration of gabapentin. The treatment of both groups lasted for 8 weeks. After the first intradermal injection, tramadol sustained-release tablets (100 mg) were administered every 12 hours for patients in both groups, and dosages of medicine was adjusted according to the pain condition, and the longest administration course was one week. The therapeutic effect, Visual Analogue Scale (VAS) scores before and after treatment, the dosage of tramadol sustained-release tablets, the quality of sleep (QS) score before and after treatment and the adverse reactions were observed and compared between the two groups.
      Results  The total effective rate of the observation group was significantly better than that of the control group (98.57% vs. 75.71%, P < 0.05). The VAS scores between the two groups before treatment showed no significant difference(P>0.05), it was significantly declined after treatment than before treatment in two groups, and the observation group was significantly lower than that of the control group (P < 0.05). The dosage of tramadol sustained-release tabletsin the observation group was significantly lower than that in the control group [(698.50±96.50) mg vs. (1 289.50±169.50) mg, P < 0.05]. There were no significant differences in adverse reactions between the two groups (P>0.05).
      Conclusion  Patients with intradermal injection of compound betamethasone in pain area have more significant efficacy than those with dexamethasone in the treatment of post-herpetic neuralgia in thoracic and dorsal regions.
  • 表  1   2组患者疗效比较[n(%)]

    组别 n 治愈 显效 有效 无效 总有效
    对照组 70 14(20.00) 14(20.00) 25(35.71) 17(24.29) 53(75.71)
    观察组 70 35(50.00) 23(32.86) 11(15.71) 1(1.43) 69(98.57)*
    与对照组比较, *P < 0.05。
    下载: 导出CSV

    表  2   2组患者治疗前、后VAS评分比较(x±s

    组别 n 治疗前 治疗后
    1周 2周 4周 6周 8周
    对照组 70 8.45±0.60 6.45±0.70* 4.28±0.68* 3.85±0.58* 2.98±0.70* 1.27±0.48*
    观察组 70 8.55±0.35 5.18±0.25*# 3.48±0.35*# 2.00±0.28*# 1.13±0.24*# 0.49±0.19*#
    与治疗前比较, *P < 0.05; 与对照组比较, #P < 0.05。
    下载: 导出CSV

    表  3   2组患者治疗前、后QS评分情况(x±s

    组别 n 治疗前 治疗后
    1周 2周 4周 6周 8周
    对照组 70 3.71±0.31 3.34±0.45* 2.35±0.25* 1.97±0.30* 1.72±0.45* 1.14±0.42*
    观察组 70 3.73±0.29 2.15±0.21*# 1.13±0.14*# 0.69±0.15*# 0.42±0.13*# 0.21±0.12*#
    与治疗前比较, *P < 0.05; 与对照组比较, #P < 0.05。
    下载: 导出CSV
  • [1] 杜晓丽. 复方倍他米松皮内注射联合氦氖激光治疗带状疱疹后遗神经痛疗效评价[J]. 中国麻风皮肤病杂志, 2015, 31(1): 34-35. https://www.cnki.com.cn/Article/CJFDTOTAL-MALA201501015.htm
    [2] 黄媛馨, 张文科. 复方倍他米松皮内注射对带状疱疹后遗神经痛的疗效观察[J]. 中国现代药物应用, 2015, 9(24): 189-190. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWYY201524145.htm
    [3] 陈诗翔, 徐敏丽. 神经根阻滞治疗89例带状疱疹后遗神经痛临床疗效观察[J]. 实用皮肤病学杂志, 2012, 5(4): 210-212, 215. doi: 10.3969/j.issn.1674-1293.2012.04.006
    [4] 张津玮, 张小宝, 崔吉正, 等. 皮内注射牛痘疫苗致炎兔皮提取物治疗带状疱疹神经痛的疗效评价[J]. 中华实验和临床病毒学杂志, 2016, 30(6): 566-569. doi: 10.3760/cma.j.issn.1003-9279.2016.06.016
    [5] 何润基, 程军胜, 陈雯莉, 等. 三种方法治疗带状疱疹后遗神经痛的疗效比较[J]. 中国皮肤性病学杂志, 2012, 26(5): 467-470. https://www.cnki.com.cn/Article/CJFDTOTAL-ZBFX201205051.htm
    [6] 李庆贤, 种树彬, 叶艳芬, 等. 复方倍他米松联合伐昔洛韦治疗带状疱疹的疗效分析[J]. 黑龙江医学, 2015, 39(8): 893-894. doi: 10.3969/j.issn.1004-5775.2015.08.013
    [7] 戴春燕. 复方倍他米松(得宝松)联合抗病毒药治疗带状疱疹疗效的观察[J]. 吉林医学, 2012, 33(1): 31-32. doi: 10.3969/j.issn.1004-0412.2012.01.013
    [8] 边芳, 蔡正良, 李亚琴, 等. 穴位注射治疗带状疱疹后遗神经痛临床疗效观察及对血清中IL-6与IL-10水平的影响[J]. 甘肃医药, 2014, 33(3): 175-177. https://www.cnki.com.cn/Article/CJFDTOTAL-GSYY201403007.htm
    [9] 陈雪吟, 叶乐, 吴玮, 等. 糖皮质激素对椎旁阻滞治疗带状疱疹后神经痛疗效的影响[J]. 国际麻醉学与复苏杂志, 2017, 38(6): 502-505. doi: 10.3760/cma.j.issn.1673-4378.2017.06.005
    [10] 郑会城. 复方倍他米松用于Hunt综合征效果分析[J]. 现代中西医结合杂志, 2015, 24(12): 1303-1305. doi: 10.3969/j.issn.1008-8849.2015.12.018
    [11] 朱德国, 王莉, 王楠楠. 脉冲射频联合复方倍他米松、臭氧治疗带状疱疹后神经痛[J]. 临床医药文献电子杂志, 2016, 3(36): 7141-7142. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201636028.htm
    [12] 张海芳, 周国明. CT引导下椎旁注射不同药物治疗早期带状疱疹后神经痛临床疗效比较[J]. 河北医学, 2016, 22(7): 1155-1157. doi: 10.3969/j.issn.1006-6233.2016.07.039
    [13] 李茜, 刘军连, 田有粮. 皮下神经阻滞治疗带状疱疹后神经痛的疗效[J]. 实用疼痛学杂志, 2016, 12(2): 129-131. https://www.cnki.com.cn/Article/CJFDTOTAL-ZTYZ202001019.htm
    [14] 袁欣, 张克进, 马飒飒, 等. 超激光疼痛治疗仪联合神经阻滞治疗带状疱疹后遗神经痛30例临床观察[J]. 中国皮肤性病学杂志, 2012, 26(2): 122-123. https://www.cnki.com.cn/Article/CJFDTOTAL-ZBFX201202013.htm
    [15] 杨梅, 章绍清, 吴艳霞, 等. 带状疱疹后遗神经痛发病相关因素及干预方法分析[J]. 现代预防医学, 2013, 40(1): 153-155, 159. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201301057.htm
    [16] 张霞, 郭建辉. 围刺加放血治疗带状疱疹36例[J]. 实用中医药杂志, 2015, 31(1): 61-62. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYAO201501057.htm
    [17] 刘建国, 赵智英, 喻国华. 中药内服外敷治疗带状疱疹64例观察[J]. 实用中医药杂志, 2012, 28(1): 14-15. doi: 10.3969/j.issn.1004-2814.2012.01.008
    [18] 朱家军, 刘金东. 445例带状疱疹后遗神经痛联合治疗的临床观察[J]. 实用临床医药杂志, 2015, 19(21): 198-199. doi: 10.7619/jcmp.201521077
  • 期刊类型引用(13)

    1. 刘倩. 难治性胃食管反流病的中医疗法研究近况. 湖北中医杂志. 2023(11): 63-66 . 百度学术
    2. 杨超,陈莉丽,杨振斌. 方晓华抑木扶土法临床运用验案举隅. 中国民间疗法. 2022(14): 105-108 . 百度学术
    3. 郭丽,夏军权,刘晓桐. 难治性胃食管反流病中医药诊治研究进展. 光明中医. 2021(22): 3790-3793 . 百度学术
    4. 贾军峰,李文萍. 和胃降逆饮联合西药及针刺治疗残胃引起的反流性食管炎的疗效及对血清胃动素的影响. 中国中西医结合消化杂志. 2020(12): 944-948 . 百度学术
    5. 刘妍. 疏肝降逆汤联合中医特色护理治疗胃食管反流病效果研究. 药品评价. 2019(01): 44-46 . 百度学术
    6. 马雪梅. 和胃降逆汤加减联合奥美拉唑、枸橼酸莫沙必利治疗肝胃郁热型胃食管反流病的临床观察. 中国民间疗法. 2019(05): 55-56 . 百度学术
    7. 房晓娜. 和胃降逆汤加减治疗胃食管反流病肝胃郁热型临床观察. 实用中医药杂志. 2019(04): 413-414 . 百度学术
    8. 邓粉会. 自拟和胃降逆汤辅助西药治疗胃食管反流病相关性支气管哮喘疗效观察. 人人健康. 2019(24): 114-115 . 百度学术
    9. 黄太伟. 半夏厚朴汤加减治疗难治性胃食管反流病的疗效研究. 实用医技杂志. 2018(06): 625-626 . 百度学术
    10. 高钟. 泮托拉唑、香砂养胃丸、左金丸联用治疗胃食管反流病的效果观察. 中国社区医师. 2018(19): 102-103 . 百度学术
    11. 姚向东. 雷贝拉唑、莫沙必利与玄麦甘桔三联用药治疗咽喉反流疾病的临床疗效. 中国合理用药探索. 2018(02): 8-11 . 百度学术
    12. 王巧凤,王胜业. 和胃降逆汤加减治疗肝胃郁热型胃食管反流病疗效观察. 北方药学. 2018(11): 131 . 百度学术
    13. 王茜茜,李华岳. 加减乌梅丸方联合穴位针刺对胃食管反流病患者食管动力的影响. 中国中医药现代远程教育. 2018(23): 42-44 . 百度学术

    其他类型引用(7)

表(3)
计量
  • 文章访问数:  341
  • HTML全文浏览量:  182
  • PDF下载量:  14
  • 被引次数: 20
出版历程
  • 收稿日期:  2019-03-02
  • 录用日期:  2019-04-09
  • 网络出版日期:  2021-02-22
  • 发布日期:  2019-05-27

目录

    /

    返回文章
    返回